ES2038597T3 - Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa. - Google Patents
Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa.Info
- Publication number
- ES2038597T3 ES2038597T3 ES198686402610T ES86402610T ES2038597T3 ES 2038597 T3 ES2038597 T3 ES 2038597T3 ES 198686402610 T ES198686402610 T ES 198686402610T ES 86402610 T ES86402610 T ES 86402610T ES 2038597 T3 ES2038597 T3 ES 2038597T3
- Authority
- ES
- Spain
- Prior art keywords
- virus
- disturbance
- water sample
- neutralizing antibodies
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 230000003472 neutralizing effect Effects 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- 239000002699 waste material Substances 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
METODOS PARA DIAGNOSTICO, PROGNOSIS, PROFILAXIS Y TERAPIA DE LAS INFECCIONES VIRICAS DESCRITAS. LOS METODOS EMPLEAN UN VIRUS, ANTIGENO VIRICO O FRAGMENTOS DE ELLOS EN LOS CUALES LA "PERTURBACION" DE LA MITAD DESGARRADA DE UN OLIGOSACARIDO DEL VIRUS, ANTIGENO VIRICO, O FRAGMENTOS DE ELLOS MAS ESPECIFICAMENTE RECONOCIBLES O REACTIVOS CON ANTICUERPOS NEUTRALIZANTES. COMO ES DESCRITO LA "PERTURBACION" DE UNA MITAD DE OLIGOSACARIDO, ABARCA SIN MODIFICACION ALGUNA (1), ALTERAR LA ESTRUCTURA QUIMICA O FISICA DEL RESIDUO DE HIDRATO DE CARBONO QUE ESTA PRESENTE NATURALMENTE; (2) ELIMINAR TOTAL O PARCIALMENTE UN RESIDUO DE CARBOHIDRATO; Y (3) PREVENIR O ALTERAR LA ADICION DE RESIDUO DE CARBOHIDRATO. UNA VARIEDAD DE METODOS DE "PERTURBACION" DE OLIGOSACARIDOS SON TAMBIEN DESCRITOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8517377A FR2590674B1 (fr) | 1985-11-25 | 1985-11-25 | Nouveaux reactifs de diagnostic |
US06/928,631 US4853326A (en) | 1985-11-25 | 1986-11-18 | Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic prophylactic and/or therapeutic applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2038597T3 true ES2038597T3 (es) | 1993-08-01 |
Family
ID=26224838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198686402610T Expired - Lifetime ES2038597T3 (es) | 1985-11-25 | 1986-11-25 | Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0229546B1 (es) |
AT (1) | ATE67314T1 (es) |
AU (1) | AU592142B2 (es) |
DE (1) | DE3681428D1 (es) |
ES (1) | ES2038597T3 (es) |
FI (1) | FI873233A (es) |
GR (1) | GR3003323T3 (es) |
WO (1) | WO1987003206A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863730A (en) * | 1986-03-21 | 1989-09-05 | Cenfold Holdings, S.A. | Immunotherapy for AIDS patients |
WO1989000196A1 (en) * | 1987-06-30 | 1989-01-12 | The Upjohn Company | Virus proteins having reduced o-linked glycosylation |
WO1989001339A1 (en) * | 1987-08-11 | 1989-02-23 | Regents Of The University Of Minnesota | Hyper-immune globulin against hiv |
US5164481A (en) * | 1989-08-23 | 1992-11-17 | Iaf Biochem International Inc. | Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
US5427792A (en) * | 1989-08-23 | 1995-06-27 | Biochem Immunosystems, Inc. | Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
DE4025499A1 (de) * | 1990-08-11 | 1992-02-13 | Sandoz Ag | Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen |
CA2538794C (en) | 2003-09-12 | 2016-04-19 | Antigenics, Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2378094A2 (fr) * | 1977-01-24 | 1978-08-18 | Inst Nat Sante Rech Med | Nouveaux reactifs biologiques constitues par des supports solides sur lesquels sont couples des composes organiques comportant un residu glucidique |
US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
JPS54113492A (en) * | 1978-02-24 | 1979-09-05 | Sanyo Chem Ind Ltd | Preparation of glucoprotein derivative |
CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
JPS6011428A (ja) * | 1983-02-01 | 1985-01-21 | ジエネンテク,インコ−ポレイテツド | 狂犬病ワクチン |
FR2543570B1 (fr) * | 1983-03-31 | 1985-08-09 | Pasteur Institut | Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains |
WO1984004327A1 (en) | 1983-04-27 | 1984-11-08 | Harvard College | Method and products for detection of human t cell leukemia virus |
US4634666A (en) * | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
US4743553A (en) * | 1984-07-18 | 1988-05-10 | W. R. Grace & Co. | Synthetic genes for bovine parainfluenza virus |
-
1986
- 1986-11-21 WO PCT/US1986/002524 patent/WO1987003206A1/en active Application Filing
- 1986-11-21 AU AU67231/87A patent/AU592142B2/en not_active Ceased
- 1986-11-25 ES ES198686402610T patent/ES2038597T3/es not_active Expired - Lifetime
- 1986-11-25 AT AT86402610T patent/ATE67314T1/de not_active IP Right Cessation
- 1986-11-25 DE DE8686402610T patent/DE3681428D1/de not_active Expired - Fee Related
- 1986-11-25 EP EP86402610A patent/EP0229546B1/en not_active Expired - Lifetime
-
1987
- 1987-07-23 FI FI873233A patent/FI873233A/fi not_active IP Right Cessation
-
1991
- 1991-12-11 GR GR91401948T patent/GR3003323T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3681428D1 (de) | 1991-10-17 |
FI873233A0 (fi) | 1987-07-23 |
EP0229546B1 (en) | 1991-09-11 |
GR3003323T3 (en) | 1993-02-17 |
AU592142B2 (en) | 1990-01-04 |
ATE67314T1 (de) | 1991-09-15 |
WO1987003206A1 (en) | 1987-06-04 |
AU6723187A (en) | 1987-07-01 |
FI873233A (fi) | 1987-07-23 |
EP0229546A1 (en) | 1987-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8801318A1 (es) | Un procedimiento para la produccion de un peptido. | |
EP0199479A3 (en) | Ozone decontamination of blood and blood products | |
DE3587941T2 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
NO873753L (no) | Periodisk biologisk luftbehandlingsprosess og system for denne. | |
DK609985A (da) | Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne | |
ES2100174T3 (es) | Nuevos anticuerpos reactivos con carcinomas humanos. | |
ES2130121T3 (es) | Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva. | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
ZA872166B (en) | Synthetic htlv-iii peptides,compositions and uses thereof | |
SE8703225D0 (sv) | Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections | |
IT8122595A0 (it) | Procedimento per il trattamento di lisato di limulo e reagente contenente il lisato trattato. | |
ES2054667T3 (es) | Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso. | |
ES2038597T3 (es) | Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa. | |
DE69333076D1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
ES2062809T3 (es) | Proteinas bacterianas del estres. | |
DE69223955T2 (de) | Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren | |
ES2114064T3 (es) | Inmunoanalisis para la deteccion de colageno o fragmentos de colageno. | |
ES547038A0 (es) | Procedimiento de preparar sondas biologicas y oligonucleoticos. | |
PT82672B (pt) | Processo para a preparacao de anticorpos monoclonais para carcinomas do pulmao de celulas nao-pequenas humanos | |
IT7819614A0 (it) | Reattore per la depurazione biologica in continuo delle acque di rifiuto, particolarmente adattoper casette per fine settimana, villini per famiglie e simili. | |
ES2059539T3 (es) | Metodo para la prevencion de la enfermedad del injerto frente al huesped. | |
ATE137674T1 (de) | Von mca 16-88 erkanntes antigen | |
ES2072331T3 (es) | Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas. | |
IT7821230A0 (it) | Procedimento per scarniere pelli e dispositivo per l'esecuzione del procedimento. | |
Sayce et al. | Human seminal orosomucoid and its possible use in medicolegal investigation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 229546 Country of ref document: ES |